In this video, Yasha S. Modi, MD, discusses 3-year data from the GALE extension study on pegcetacoplan for the treatment of geographic atrophy, presented at the American Academy of Ophthalmology meeting.
The data showed that there was continued separation between the treatment arm and the sham arm, Modi said.
“What was interesting was they crossed over patients who were previously receiving sham, and the slope of that geographic atrophy progression diminished, which was very exciting to see,” Modi, associate professor, department of ophthalmology at NYU Grossman School of Medicine,